Literature DB >> 26679254

New insights into the survival mechanisms of rifampicin-resistant Mycobacterium tuberculosis.

Du Toit Loots1.   

Abstract

OBJECTIVES: Rifampicin is considered the most important antibiotic for treating TB, but unfortunately Mycobacterium tuberculosis is rapidly developing resistance to this drug. Despite the fervent research efforts to date, TB is still a major global problem, and hence new approaches are necessary to better characterize this disease, especially the mechanisms relating to drug resistance.
METHODS: Using a two-dimensional GC-coupled time-of-flight MS metabolomics approach, the most important metabolite markers characterizing rifampicin-resistant M. tuberculosis were identified.
RESULTS: The metabolite markers identified indicate instability in rifampicin-resistant M. tuberculosis mRNA, induced by the rpoB mutation. This results in a total depletion of aconitic acid, due to a shift in aconitase functionality towards mRNA binding and stability, and away from energy production and growth, and a subsequent increased dependency on alternative energy sources, fatty acids in particular. A number of other metabolic changes were observed, confirming an additional survival response for maintaining/remodelling the cell wall.
CONCLUSIONS: This study shows the value of a metabolomics approach to biological investigations in a quest to better understand disease-causing organisms and their tolerance to existing medications, which would in the future undoubtedly assist in the development of alternative treatment approaches.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26679254     DOI: 10.1093/jac/dkv406

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

Review 1.  Emerging Approaches to Tuberculosis Drug Development: At Home in the Metabolome.

Authors:  Robert S Jansen; Kyu Y Rhee
Journal:  Trends Pharmacol Sci       Date:  2017-02-03       Impact factor: 14.819

2.  Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis.

Authors:  Soujanya D Yelamanchi; Archita Mishra; Santosh Kumar Behra; Gayathree Karthikkeyan; Thottethodi Subrahmanya Keshava Prasad; Avadhesha Surolia
Journal:  Metabolites       Date:  2022-05-29

3.  [Mass spectrometry-based identification of new serum biomarkers in patients with multidrug resistant pulmonary tuberculosis].

Authors:  Dongzi Lin; Wei Wang; Feng Qiu; Yumei Li; Xiaolin Yu; Bingyao Lin; Yinwen Chen; Chunyan Lei; Yan Ma; Jincheng Zeng; Jie Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-12-30

4.  Characterization of Genetic Variants Associated with Rifampicin Resistance Level in Mycobacterium tuberculosis Clinical Isolates Collected in Guangzhou Chest Hospital, China.

Authors:  H M Adnan Hameed; Cuiting Fang; Zhiyong Liu; Yanan Ju; Xingli Han; Yamin Gao; Shuai Wang; Gift Chiwala; Yaoju Tan; Ping Guan; Jinxing Hu; Xiaoli Xiong; Jiacong Peng; Yongping Lin; Muzammal Hussain; Nanshan Zhong; Dmitry A Maslov; Gregory M Cook; Jianxiong Liu; Tianyu Zhang
Journal:  Infect Drug Resist       Date:  2022-09-27       Impact factor: 4.177

5.  A Screening of the MMV Pandemic Response Box Reveals Epetraborole as a New Potent Inhibitor against Mycobacterium abscessus.

Authors:  Taeho Kim; Bui-Thi-Bich Hanh; Boeun Heo; Nguyenthanh Quang; Yujin Park; Jihyeon Shin; Seunghyeon Jeon; June-Woo Park; Kirandeep Samby; Jichan Jang
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

6.  Repurposing clinically approved cephalosporins for tuberculosis therapy.

Authors:  Santiago Ramón-García; Rubén González Del Río; Angel Santos Villarejo; Gaye D Sweet; Fraser Cunningham; David Barros; Lluís Ballell; Alfonso Mendoza-Losana; Santiago Ferrer-Bazaga; Charles J Thompson
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

7.  Untargetted Metabolomic Exploration of the Mycobacterium tuberculosis Stress Response to Cinnamon Essential Oil.

Authors:  Elwira Sieniawska; Rafał Sawicki; Joanna Golus; Milen I Georgiev
Journal:  Biomolecules       Date:  2020-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.